Nuvectis Pharma Inc. NVCT
$11.66
▲ +1.90% 24H
About
Nuvectis Pharma Inc. is a biopharmaceutical company engaged in the development and commercialization of innovative cancer treatments. Its primary function is to explore novel therapies that address significant unmet medical needs in oncology. The company focuses on advancing proprietary compounds through clinical trial…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees12
TickerNVCT
Statistics
Market Cap$309.3M
Revenue (TTM)—
Net Income-$26.4M
Net Margin—
EPS$-1.32
P/E-7.95
P/S—
P/B18.28
EV/EBITDA-8.52
ROE-154.4%
Dividend Yield—
Price$11.66
Data: Twelve Data · Revenue = mcap / P/S